basic aspects about drugs
play

Basic Aspects about Drugs Dr.Suryaprakash Dhaneria M.D. - PowerPoint PPT Presentation

Basic Aspects about Drugs Dr.Suryaprakash Dhaneria M.D. (Pharmacology), D.M.(Clinical Pharmacology), D.N.B.(Clinical Pharmacology & Therapeutics) M.Sc.(Bio chemistry), LL.B.(Hons.) MNAMS Dean (Academics) Professor & Head Department


  1. Basic Aspects about Drugs Dr.Suryaprakash Dhaneria M.D. (Pharmacology), D.M.(Clinical Pharmacology), D.N.B.(Clinical Pharmacology & Therapeutics) M.Sc.(Bio chemistry), LL.B.(Hons.) MNAMS Dean (Academics) Professor & Head Department of Pharmacology All India Institute of Medical Sciences Raipur (C.G.)

  2. Drugs It is a substance used for diagnosis, prevention, treatment of disease or alteration of physiological state. PHARMACOLOGY A branch of medical science which deals about the knowledge of drugs.

  3. Drug Nomenclature  Chemical name  Generic name (O fficial/approved/non- proprietary)  Brand or trade name (proprietary)

  4. Medicine Strip - Information Generic name Indian Dosage form (Non-proprietary Pharmacopeia name) Brand name Strength of (Proprietary name) tablet Manufacturer Batch No. Manufacturing date Expiry date

  5. Sources of Drugs 1. Plants 2. Animals 3. Micro-organisms (fungi, bacteria) 4. Minerals 5. Synthetic 6. DNA recombinant technology

  6. Plant source – Examples Drug : Morphine Plant : Papaver somniferum Parts of plant used: Unripe capsule, seeds Drug Class: Opioid analgesics Use: • Acute and chronic severe pain • Acute myocardial infarction • Acute pulmonary edema

  7. Plant source – Examples Drug : Digitalis Plant : Digitalis lanata Parts of plant used: Leaves, flowers Drug Class: Cardiac glycosides Use: • Congestive heart failure

  8. Plant source – Examples Drug : Artesunate Plant : Artemisia annua Parts of plant used: Leaves Drug Class: Antimalarial drugs Use: • Treatment of malaria

  9. Plant source – Examples Drug : Atropine Plant : Atropa belladonna, Datura stramonium Parts of plant used: Fruits, seeds, flowers Drug Class: Anticholinergic drugs Use: • Organophosphate poisoning • Corneal ulcer • Refractive error testing

  10. Plant source – Examples Drug : Quinine Plant : Cinchona officinalis Parts of plant used: Bark Drug Class: Antimalarial drugs Use: • Treatment of malaria

  11. Plant source – Examples Drug : Vincristine, Vinblastine Plant : Catharanthus roseus (Vinca rosea) Parts of plant used: Flowers Drug Class: Antineoplastic drugs Use: • Acute lymphocytic leukaemia • Non-Hodgkin’s lymphoma • Hodgkin’s lymphoma

  12. Insulin

  13. Heparin Protamine Vitamin D

  14. Minerals as source of drugs • Ferrous sulphate for treatment of Iron deficiency anemia. • Aluminium hydroxide + Magnesium hydroxide for the management of hyperacidity. Human as a source of drugs Human source Drugs Uses Urine of Female Human menopausal postmenopausal Infertility gonadotropins (Menotropin) women treatment Female Placenta and urine of Human chorionic gonadotropin Infertility pregnant woman (hCG) treatment For lysis of clot Urokinase Human kidney cells in AMI.

  15. Oral formulations Capsule Lozenge Tablet Syrup Granules Suspension

  16. Parenteral formulations Ampoules Vial Saline bottle & Infusion set

  17. Topical formulations Ointment Ear drop Gels (Jellies) Eye drop RECTAL Transdermal Inhaler (Suppository) patches

  18. Indication  Clinical condition in which drug is used Contra-indication  Clinical condition in which drug should not be used For combined pill (Estrogen + Progestin) Indication – for female contraception Contraindication – Deep vein thrombosis

  19. Adverse drug reactions Any response to drug which is noxious and unintended occuring at doses normally used in man for prophylaxis, diagnosis or treatment of a disease or for the modification of physiological function.

  20. Adverse Drug Reactions • Moon facies (Cushingoid facies) • Glucocorticoids

  21. Adverse Drug Reactions • Steven’s Johnson Syndrome • Sulpha drugs

  22. Adverse Drug Reactions • Yellowish discoloration of teeth • Tetracycline

  23. Adverse Drug Reactions • Gingival hyperplasia • Phenytoin

  24. Adverse Drug Reactions • Angioedema • ACE inhibitors – Enalapril – Lisinopril

  25. Adverse Drug Reactions • Ankle edema • Calcium channel blockers

  26. Drug Development Animal studies Phase I clinical trial Phase II clinical trial Phase III clinical trial Post-marketing surveillance

  27. Pharmacovigilance Is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effect or any other possible drug related problems.

  28. Who can report ADR ? Doctor Dentist Nurse Pharmacist Patient

  29. Patient Details 1. Patient initials___________________ jksxh ds gLrk{kj % (In confidence). 2. Gender/ fyax Male/ iq:’k Female / L=h Other / vU; 3. Age (Y ears or month)_____________ vk;q ¼o’kZ ;k ekg½

  30. Health Information a. Reason(s) for taking medicine(s) (Disease/ S ymptoms): nok ¼nok,a½ ysus dk dkj.k ¼jksx@y{k.k½%

  31. Health Information b. Medicines Advised by/ ( √ ) : nokbZ dh lykg nsus okyk % Doctor/ MkWDVj Pharmacist/ QkekZflLV Friends/ Relatives/ fe=@fj”rsnkj elf (Past disease experienced/ No S past disease experienced)/ Lo;a ¼iwoZ chekjh dk vuqHko@iwoZ chekjh dk dksbZ vuqHko ugha½

  32. Details of person reporting the side effect nq"izH izHkko kko dh dh lw lwpu puk ns nsus us okys okys O; O;fD fDr dk f fooj ooj.k Name (Optional)/ uke ¼ e ¼oS oSdfYid½ _____________ Address/ irk% rk% ___________________________ ___________________________ Telephone No. / Vsyh yhQksu su ua ua __________________ E-mail / bZ bZes esy : ___________________________

  33. Details of Medicine taking/taken yh t tk pq pqdh n nokbZ okbZ dk fooj ooj.k Name of Medicine / nok nokb;ksa d ds uke uke Quantity of Medicine taken (Dose, frequency) Expiry date of Medicine / yh yh xbZ xbZ no nokbZ dh dh ek ek=k =k ¼mn mnkg kgj.k ds fy fy, 250 250 fe fexz xzk- ,d ,d fnu nu esa esa nks nks ckj½ kj½ – Expiry Date of Medicines / no nok ds s fuf’dz ’dz; ; gks gksus us dh h fr frfF fFk – Date of start of Medicines/ no nokb kb;ka vkj kjaHk Hk djus us dh h fr frfFk fFk – Date of stop of Medicines/ no nokb kb;ka ka jksdus us djus us dh h fr frfFk fFk o:i ( √ ) : Dosage form / [kqjkd kqjkd dk k Lo: Tablet / xksyh yh ¼Vscy cysV sV½ ½ Capsule/ dSI SIlwy , Injection/ batsD” D”ku Oral liquids/ ekS ekSf[kd kd rjy rjy If others (Please specify…….) / ;fn n vU vU; ¼ ; ¼d` d`i;k ;k fu fufn fnZ’V ’V djs djsa ----- ----- ------ ----½

  34. About the side effect / nq’izHkko Hkko ds ds ck ckjs esa esa When did the side effect started? / nq"izHkko Hkko dh dh “ “kq:vkr kr dc dc gqbZ Fk Fkh\ When did the side effect stop? nq"izHkko Hkko dc dc le lekI kIr gqvk gqvk Fk Fkk \ Side effect is still continuing – Yes/No D;k D;k nq" q"izHk zHkko tk tkjh jh gS ¼gka@ a@ugha½ gha½%

  35. How bad was the Side Effect? (Please √ the boxes that Apply) nq" nq"izHkk zHkko fdrus rus gkf gkfud udkjd Fks ks\ ij √ dk fu” ¼ d`i; i;k tks ks ykxw xw gks gks] m ml l ij u”kku kku yxk yxk,a½ Did not affect daily activities/ nS nSfud ud xfrfof fof/k;ka izHkkf zHkkfor ugha ugha gqb gqbZ Fkh kh\ Affect daily activities nS nSfud ud xfrfof fof/k;ka izHkkf zHkkfor gqb gqbZ Admitted to hospital/ vLirk rky ys ys tkuk kuk iM+k +k Death / e`R; `R;w Others / vU;

  36. Describe the Side Effect (What did you do to manage the side effect?) nq"izH izHkko kko dh dh O;k ;k[;k ;k dj djsa ¼vkiu kius nq’izHk ’izHkko koks ksa ls ls Nq NqVdkj kjk izk izkIr djus jus ds ds fy fy, , D;k D;k fd;k d;k½ \

  37. Confidentiality: • The patient’s identity is held in strict confidence and protected to the fullest extent. Programme staff is not expected to and will not disclose the reporter’s identity in response to a request from the public. xks ksiuh;rk% jk jksxh dh dh ig igpku dk dks iw iw.kZr kZr% xqIr vkSj Sj lqj lqjf{kr kr j[ j[kk kk tkr krk gS A dk dk;Zdz dze ds ds LV LVkQ ls ls mEehn dh dh tk tkrh rh gS fd fd LV LVkQ dk dk dksbZ bZ Hkh Hkh O;fDr fDr lk lkoZt Ztfud vuqj qjks ks/k /k ij ij fj fjiksV sVZ nsus okys ys dh dh ig igpku dk dk [kqyklk klk ugh gh djsx djsxk A

  38. S฀฀฀ ฀฀฀฀ ฀ ฀฀฀฀ ฀ ฀฀ ฀฀฀ ฀ ฀฀ ฀ ฀฀ ฀ ฀ Pharmacovigilance Programme of India National Coordination Centre, Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt. of India Sector-23,Rajnagar, Ghaziabad-201002. Uttar Pradesh Tel.: 0120-2783400, 2783401, 2783392 Fax: 0120-2783311 Email: pvpi.compat@ gmail.com For more information visit us at w w w.ipc.gov.in

  39. C฀฀ ฀ ฀฀ ฀฀ H฀฀ ฀฀ ฀ ฀฀ 1800180-3024 (Toll Free) (9.00 AM to 5.30 PM, w eekdays)

  40. Guidelines for Rational Use of Drugs

  41. Newer drugs are always better drugs.  Costly drugs are always better drugs.  Polypharmacy is always better. 

  42. Antibiotics have saved our lives for so long and now it is the time for us to save antibiotics.

  43. “The drugs that satisfy the healthcare needs of majority of the population, therefore these should be available at all times, at all the places, in adequate amount, in appropriate dosage form and at affordable cost.”

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend